Clinical Trials · NCT01562678
Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Enrollment
- 28
- Start date
- Mar 2012
- Locations
- 1 site, United States
- Primary endpoint
- Change Between Highly Desirable vs. Less Desirable Food Cues in the Effect Size of Cortical Activation During Food Visualization